OnabotulinumtoxinA for Chronic Migraine
- 23 January 2012
- journal article
- expert opinion
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 57 (10) , E10-E16
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialCephalalgia, 2010
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trialCephalalgia, 2010
- Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type ACephalalgia, 2009
- Botulinum Toxin A in the Treatment of Chronic Tension‐Type Headache With Cervical Myofascial Trigger Points: A Randomized, Double‐Blind, Placebo‐Controlled Pilot StudyHeadache: The Journal of Head and Face Pain, 2009
- Efficacy of botulinum toxin type A in new daily persistent headacheThe Journal of Headache and Pain, 2008
- Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in AdultsCephalalgia, 2008
- Botulinum Toxin Occipital Nerve Block for the Treatment of Severe Occipital Neuralgia: A Case SeriesPain Practice, 2007
- Botulinum toxin type-A therapy in cluster headache: an open studyThe Journal of Headache and Pain, 2007
- Botulinum Toxin Type A (BOTOX ® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled TrialHeadache: The Journal of Head and Face Pain, 2005
- Does Single‐File Botox Injection Really Work for Primary Headache?Headache: The Journal of Head and Face Pain, 2004